Treat SEPS ‘no differently than any other patent’, USPTO says
Standards-essential patents (SEPs) should be treated “nodifferently than any other patent”, exclaims as a policy statement
from the US
Patent and Trademark Office (USPTO), the National Institute of Standards and
Technology (NIST) and the Department of Justice’s Antitrust Division.
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.